Company Jafron Biomedical Co.,Ltd.
Equities
300529
CNE100002995
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.9 CNY | +2.76% |
|
+1.42% | +25.51% |
Business Summary
Number of employees: 2,408
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Disposable Blood Perfusion Device
76.4
%
| 2,025 | 81.3 % | 1,468 | 76.4 % | -27.50% |
Blood Purification Equipment
12.3
%
| 198 | 7.9 % | 236 | 12.3 % | +19.26% |
Disposable Plasma Bilirubin Absorber
4.8
%
| 115 | 4.6 % | 92 | 4.8 % | -20.13% |
Other
3.6
%
| 79 | 3.2 % | 70 | 3.6 % | -11.58% |
Hemodialysis Powder and Liquid Products
2.9
%
| 75 | 3.0 % | 57 | 2.9 % | -24.09% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
97.3
%
| 2,429 | 97.5 % | 1,870 | 97.3 % | -23.01% |
Overseas
2.7
%
| 62 | 2.5 % | 52 | 2.7 % | -16.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Fan Dong
CEO | Chief Executive Officer | 54 | 98-12-31 |
Yao Hong Chen
BRD | Director/Board Member | 45 | 12-12-31 |
Feng Li
BRD | Director/Board Member | 54 | 09-12-31 |
Xian Min Tang
BRD | Director/Board Member | 54 | 99-07-31 |
Cong Huang
SEC | Corporate Secretary | 32 | 19-05-31 |
De Zhi Li
PRN | Corporate Officer/Principal | 58 | 04-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Qing Guo
BRD | Director/Board Member | 62 | 23-04-20 |
Yan Jun Xu
BRD | Director/Board Member | 51 | 23-04-20 |
Fan Dong
CEO | Chief Executive Officer | 54 | 98-12-31 |
Xian Min Tang
BRD | Director/Board Member | 54 | 99-07-31 |
Zhi Hao Wen
BRD | Director/Board Member | 58 | 13-12-24 |
58 | - | ||
Feng Li
BRD | Director/Board Member | 54 | 09-12-31 |
Xiao Hong Peng
CHM | Chairman | 64 | 17-03-14 |
Yao Hong Chen
BRD | Director/Board Member | 45 | 12-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 807,555,312 | 388,787,572 ( 48.14 %) | 31,364,079 ( 3.884 %) | 48.14 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
14,804,287 | 2.89% | 56,364,214 $ |
Company contact information
![address Jafron Biomedical Co.,Ltd.(300529)](https://cdn.zonebourse.com/static/address/30620063.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.51% | 2.97B | |
-4.72% | 182B | |
-2.83% | 103B | |
-5.01% | 66.94B | |
+15.53% | 46.73B | |
-8.53% | 45.14B | |
+5.82% | 41.57B | |
+17.67% | 30.48B | |
+14.00% | 24.26B | |
-8.08% | 23.58B |
- Stock Market
- Equities
- 300529 Stock
- Company Jafron Biomedical Co.,Ltd.